Shanghai Haixin Group Co Ltd B (900917) - Total Liabilities

Latest as of March 2026: $813.34 Million USD

Based on the latest financial reports, Shanghai Haixin Group Co Ltd B (900917) has total liabilities worth $813.34 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Shanghai Haixin Group Co Ltd B annual equity growth to track the company's year-over-year net asset growth rate.

Shanghai Haixin Group Co Ltd B - Total Liabilities Trend (2015–2025)

This chart illustrates how Shanghai Haixin Group Co Ltd B's total liabilities have evolved over time, based on quarterly financial data. See Shanghai Haixin Group Co Ltd B (900917) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Shanghai Haixin Group Co Ltd B Competitors by Total Liabilities

The table below lists competitors of Shanghai Haixin Group Co Ltd B ranked by their total liabilities.

Company Country Total Liabilities
Genelux Corporation Common Stock
NASDAQ:GNLX
USA $9.45 Million
Garuda Maintenance Facility AeroAsia Tbk PT
JK:GMFI
Indonesia Rp658.98 Million
China Electric Manufacturing Corp
TW:1611
Taiwan NT$1.28 Billion
Digital Aria Co Ltd
KQ:115450
Korea ₩54.79 Billion
Kyeryong Const
KO:013580
Korea ₩2.23 Trillion
Bioxyne Ltd
AU:BXN
Australia AU$14.45 Million
CYGNUS Metals Ltd
AU:CY5
Australia AU$6.77 Million
MSM Malaysia Holdings Bhd
KLSE:5202
Malaysia RM1.14 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Shanghai Haixin Group Co Ltd B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Haixin Group Co Ltd B market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 5.61 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Haixin Group Co Ltd B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Haixin Group Co Ltd B (2015–2025)

The table below shows the annual total liabilities of Shanghai Haixin Group Co Ltd B from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $925.47 Million +11.44%
2024-12-31 $830.43 Million +7.11%
2023-12-31 $775.29 Million -14.92%
2022-12-31 $911.22 Million -12.62%
2021-12-31 $1.04 Billion -16.28%
2020-12-31 $1.25 Billion +12.21%
2019-12-31 $1.11 Billion +25.54%
2018-12-31 $884.20 Million -6.16%
2017-12-31 $942.20 Million -13.48%
2016-12-31 $1.09 Billion -12.26%
2015-12-31 $1.24 Billion --

About Shanghai Haixin Group Co Ltd B

SHG:900917 China Conglomerates
Market Cap
$120.96 Million
Market Cap Rank
#18487 Global
#4667 in China
Share Price
$0.26
Change (1 day)
+0.00%
52-Week Range
$0.24 - $0.29
All Time High
$0.82
About

Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics… Read more